LAPAROSCOPIC LYMPH NODE RESECTION OF POST-CHEMOTHERAPY (POST-CHT) RESIDUAL RETROPERITONEAL (RP) TUMOR MASSES IN PATIENTS WITH NON-SEMINOMATOUS TESTICULAR GERM-CELL TUMORS (NSTGCT)

被引:0
|
作者
Sullivan, I. G. [1 ]
Anguera, G. [1 ]
Arqueros, C. [1 ]
Condori, D. [1 ]
Palou, J. [2 ]
Pena, J. A. [2 ]
Villavicencio, H. [2 ]
Maroto, P. [1 ]
机构
[1] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[2] Fundacio Puigvert, Dept Urol, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:292 / 292
页数:1
相关论文
共 50 条
  • [31] Limited post-chemotherapy retroperitoneal resection of residual tumour in non-seminomatous testicular cancer: complications, outcome and quality of life
    Schmidt, Anna Hartmann
    Hoyer, Morten
    Jensen, Bent Frode Skov
    Agerbaek, Mads
    ACTA ONCOLOGICA, 2018, 57 (08) : 1084 - 1093
  • [32] Post-chemotherapy robot-assisted retroperitoneal lymph node dissection in non-seminomatous germ cell tumor of testis: Feasibility and outcomes of initial cases
    Islamoglu, Ekrem
    Ozsoy, Cagatay
    Anil, Hakan
    Aktas, Yasin
    Ates, Mutlu
    Savas, Murat
    TURKISH JOURNAL OF UROLOGY, 2019, 45 (02): : 113 - 117
  • [33] TOTAL LYMPH NODE YIELD IMPACTS OVERALL SURVIVAL FOLLOWING POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION FOR NON-SEMINOMATOUS TESTICULAR CANCER
    Bhanvadia, Raj
    Rodriguez, Joseph, III
    Eggener, Scott
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1040 - E1041
  • [34] RESIDUAL RETROPERITONEAL TUMOR-TISSUE IN PATIENTS TREATED FOR METASTATIC NON-SEMINOMATOUS TESTICULAR GERM-CELL TUMORS - AN IMMUNOHISTOCHEMICAL INVESTIGATION
    JACOBSEN, GK
    OLSEN, J
    TUMOUR BIOLOGY, 1985, 6 (01): : 25 - 35
  • [35] Serum miRNA to predict post-chemotherapy viable disease in testicular non-seminomatous germ cell tumor patients.
    Leao, Ricardo Romao Nazario
    Van Agthoven, Ton
    Figueiredo, Arnaldo
    Fadaak, Kamel
    Castelo-Branco, Pedro
    Jewett, Michael A. S.
    Sweet, Joan
    Ahmad, Ardalan
    Anson-Cartwright, Lynn
    Bedard, Philippe L.
    Chung, Peter W. M.
    Hansen, Aaron Richard
    Warde, Padraig Richard
    O'Malley, Martin
    Looijenga, Leendert
    Hamilton, Robert James
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [36] IS THE PERCENTAGE OF TERATOMA IN THE ORCHIECTOMY SPECIMEN PREDICTIVE OF TERATOMA IN THE RETROPERITONEUM AT THE TIME OF POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION IN MEN WITH NON-SEMINOMATOUS GERM CELL TUMORS?
    Calaway, Adam
    Speir, Ryan
    Barboza, Marcelo
    Dougwali, Antoin
    Masterson, Timothy
    Foster, Richard
    Einhorn, Lawrence
    Cary, Clint
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1017 - E1018
  • [37] Unilateral Post-Chemotherapy Robot-Assisted Retroperitoneal Lymph Node Dissection for Stage II Non-Seminomatous Germ Cell Tumors: Sexual and Reproductive Outcomes
    Tufano, Antonio
    Cilio, Simone
    Spena, Gianluca
    Izzo, Alessandro
    Castaldo, Luigi
    Grimaldi, Giovanni
    Muscariello, Raffaele
    Franzese, Dario
    Quarto, Giuseppe
    Autorino, Riccardo
    Passaro, Francesco
    Perdona, Sisto
    CANCERS, 2024, 16 (12)
  • [38] Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection for men with CII non-seminomatous germ cell tumors and a radiographically normal retroperitoneum.
    Karellas, Michael
    Carver, Brett S.
    Stasi, Jason
    Motzer, Robert J.
    Bost, George J.
    Sheinfeld, Joel
    JOURNAL OF UROLOGY, 2007, 177 (04): : 277 - 277
  • [39] The current status of laparoscopic retroperitioneal lymph node dissection for non-seminomatous germ-cell tumors
    Carver, BS
    Sheinfeld, J
    NATURE CLINICAL PRACTICE UROLOGY, 2005, 2 (07): : 330 - 335
  • [40] Post-chemotherapy retroperitoneal resection of residual masses in germ cell cancer with modified template resection
    Heidenreich, A. N.
    Pfister, D.
    Ohlmann, C. H.
    Witthuhn, R.
    Albers, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)